Supplementary Table S7 from Preclinical Evaluation of 9MW2821, a Site-Specific Monomethyl Auristatin E–based Antibody–Drug Conjugate for Treatment of Nectin-4–expressing Cancers

作者：Wei Zhou, Peng Fang, Dongan Yu, Hongyuan Ren, Meng You, Long Yin, Fei Mei, Huikai Zhu, Zhenzhen Wang, Hui Xu, Yuxia Cao, Xiaowei Sun, Xiaohong Xu, Jianjun Bi, Jin Wang, Lanping Ma, Xin Wang, Lin Chen, Yongliang Zhang, Xiaowei Cen, Xi Zhu, Liguang Lou, Datao Liu, Xiaoding Tan, Jinliang Yang, Tao Meng, Jingkang Shen · 年份：2025 · DOI：10.1158/1535-7163.30733702 · 研究领域：HER2/EGFR in Cancer Research、Toxin Mechanisms and Immunotoxins、Polysaccharides and Plant Cell Walls

<p>Binding affinity of MW282 mAb, 9MW2821, and enfortumab vedotin based on enzyme linked immunosorbent assay</p>